Supplementary Legends from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Journal
American Association for Cancer Research
Date Issued
2023-03-31
Author(s)
Debashis Sarker
Ruth Plummer
Tim Meyer
Mikael H. Sodergren
Bristi Basu
Cheng Ean Chee
et al.,
Type
preprint